Thursday, September 22, 2022

Fw: Ref.: (LML) Anúncio de um webinar em português - Announcement of a webinar in Portuguese

 


Leprosy Mailing List – September 22, 2022

 

Ref.:  (LML) Anúncio de um webinar em português - Announcement of a webinar in Portuguese

 

From:  Henk Eggens,  Santa Comba Dão, Portugal

 

 

Dear Pieter,


We would be grateful if you could share the following announcement with your LML-readers. We aim at Portuguese-speaking readers.


The message in Portuguese comes first, the English translation follows suit.
The agenda, an explanatory text about the organizing group FOLLCH and a poster of the webinar are attached.

Thank you,


Henk Eggens
Member of the FOLLCH coordinating committee

 

Caro Pieter,


Ficaríamos gratos se você puder compartilhar o seguinte anúncio com seus leitores de LML, destinado a leitores de língua portuguesa.


A mensagem em português vem primeiro, a versão em inglês está abaixo.

Em anexo três arquivos: A agenda do Webinar, um texto de apresentação do Fórum FOLLCH e o póster do webinar.

Obrigado,


Henk Eggens
Membro do comitê coordenador da FOLLCH.

-----------------------------------------------------------------------------------------------------------

Participe do Primeiro Fórum Lusófono de Luta Contra Hanseníase!

 

O fórum vai reunir pessoas envolvidas com hanseníase/lepra nos países lusófonos. Haverá palestras em português mostrando diferentes experiências e opiniões. Esperamos que os laços sejam fortalecidos.

 

Você é profissional de saúde, pessoa afetada pela hanseníase ou gestor? Gostaríamos de contar com sua presença no webinar. Esse será um evento gratuito e contará com pessoas dos países lusófonos. Sua presença é super importante para nós na construção de melhores caminhos para um mundo sem hanseníase/lepra.

 

Precisa de mais informações? Mande um email para lusohansen.follch@gmail.com.

 

Sinta-se à vontade para partilhar entre seus contatos/redes este evento tão importante para a comunidade lusófona.

 

LINK para o Webinar nos dias 5 e 6 de outubro 2022.:

 

Participe na reunião Zoom

 

https://us02web.zoom.us/j/83876784588?pwd=UEFGRUJnWmhLMnNiMlFBd2xnT3pQdz09

 

ID da reunião: 838 7678 4588

Senha: luso123

------------------------------------------------------------------------------------------------------------------------------------------

 

Participate in the First Lusophone Forum to Fight Leprosy!

 

The forum will bring together people involved with Hansen's disease/leprosy in Portuguese-speaking countries. There will be lectures in Portuguese showing different experiences and opinions. We hope ties will be strengthened.

 

Are you a healthcare professional, person affected by leprosy or manager? We would like to count on your presence in the webinar. This will be a free event and will feature people from Portuguese-speaking countries. Your presence is super important to us in building better paths for a world without Hansen's disease/leprosy.

 

Do you need more information? Send an email to lusohansen.follch@gmail.com.

 

Feel free to share this important event for the Portuguese-speaking community among your contacts/networks.

 

LINK to the Webinar:

 

Join the Zoom meeting on October 5 and 6, 2022.

 

https://us02web.zoom.us/j/83876784588?pwd=UEFGRUJnWmhLMnNiMlFBd2xnT3pQdz09

 

Meeting ID: 838 7678 4588

Password: luso123

--

FOLLCH – Fórum Lusófono de Luta Contra Hanseníase é uma plataforma de cooperação de profissionais de saúde nos países lusófonos na luta contra a Hanseníase.

FOLLCH – Lusophone Forum for the Fight Against Leprosy is a platform of health professionals in Lusophone countries in the fight against leprosy.

A Comissão Organizadora/The organizing committee.. 

 

Dr. Francisco Guilengue – Chefe do Programa Nacional de Controlo da Lepra, Moçambique. 

Dr. Ernesto Afonso – Coordenador do Programa Nacional de Lepra, Angola.

Drª. Laila de Laguiche – Presidente e Fundadora da ONG Aliança Contra Hanseníase; Membro do Board CIOMAL, Brasil.

Drª Eva de Carvalho – Ponto focal da malária e DTN, Organização Mundial de Saúde, Moçambique.

Dr. Henk Eggens – Consultor em Saúde Pública.

Drª. Maria de Jesus Freitas de Alencar – Pesquisadora e consultora independente em Saúde Pública, Portugal.

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/9e8d3ff2-2369-4726-b3b8-cf8f690e2f06n%40googlegroups.com.

Tuesday, September 20, 2022

Fw: Ref.: (LML) Leprosy Mailing List

 

 
Leprosy Mailing List – September 20,  2022

 

Ref.:  (LML) Leprosy Mailing List

 

From:  Laila de Laguiche, Curitiba, Brazil

 

 

Dear Pieter,

 

In response to your September 16th email "Leprosy Mailing List",
LML has done an extraordinary and extremely democratic job. Being managed very sparingly, it saves our time that can be unnecessarily consumed in CoPs-like platforms. Personally, I also believe that these platforms would not be so easily accessible to everyone, especially our colleagues located in countries with low-quality internet data provision.


I hope that the LML will continue to do this herculean work, helping everyone to have a more comprehensive and realistic view of the problem of leprosy in the world.

 

Laila de Laguiche

Brazil


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/048a960f-066c-4336-ba00-a7df1bc8c88fn%40googlegroups.com.

Friday, September 16, 2022

Fw: Ref.: (LML) Leprosy Mailing List

 

 

Leprosy Mailing List – September  16,  2022

Ref.:  (LML) Leprosy Mailing List

From:  Pieter AM Schreuder, Maastricht, the Netherlands


Dear colleagues,


The leprosy mailing list (LML) is an email-based list for sharing information among people working in the field of leprosy worldwide (Editorial Leprosy Review 2012). The first part of this letter is to welcome the newcomers to LML. The second part of this letter is of interest to all LML readers.

 

LML was started by Salvatore Noto in February 2001 at the Centre for Training and Research in Public Health (Cefpas) in Caltanissetta, Italy; from 2005 – 2013 held at the National Leprosy Referral Centre, Department of Dermatology, at San Martino University Hospital, in Genoa, Italy; and since 2013 moderated by Pieter AM Schreuder, Maastricht, the Netherlands. To contact Dr Pieter Schreuder <editorlml@gmail.com>

 

LML is independent and has no financial ties to any governmental or non-governmental organization or the World Health Organization (WHO). The editorial Board consists of Sunil Deepak, Ben Naafs, Salvatore Noto and Pieter Schreuder. All information passes its editorial board before being distributed. However, opinions expressed are those of the contributors and not necessarily shared by the editorial board.

 

LML accepts all contributions as long as they are relevant to leprosy. For a good understanding: LML contributions are not considered publications as a publication in a recognised recognized scientific journal. They can (and are) however be cited because represent representing professional opinions.

 

A good example of the impartiality of LML was the discussion about "elimination" (or for example "PEP"). Although the feelings about elimination on both sides of the battle ground run high, and this issue absorbed many people in the field, there did and does not exists exist a stated LML opinion. However, LML editors can on personal title contribute to the discussion as long as it is clear that they do not claim to express an "official" LML opinion.

 

LML is an open forum which that brings you in contact with almost 600 persons engaged in leprosy related work (from scientists to leprosy field workers, government officials to non-governmental organisations) in more than 50 countries. We like to hear the voices of all LML subscribers. Although not many people contribute actively to the discussions, many LML readers appreciate our efforts to show different opinions as was the case with the "elimination" discussion.

 

Over the past few years, we have seen a kind of turn-around in leprosy control: from attention to prevalence (elimination as a public health problem) to incidence (reducing transmission), from only passive case-reporting to providing funds for active case-finding activities to promote early detection and prevent nerve damage, renewed attention to detection and treatment of silent neuritis, treatment of reactions and prevention of further disability, upgrading skin smear services, attention to possible drug and multidrug resistance in leprosy, the importance of post-MDT chemoprophylaxis in the case of LL patients, Post-Exposure Prophylaxis (PEP) in leprosy, promoting respect for human rights, etc. LML provides a widely-read platform for important discussions on such topics. For previous mails look up LML blog link: http://leprosymailinglist.blogspot.it/

 

Recently, suggestions have been made to transform LML into an online Community of Practice (CoPs). Community of Practice is a vehicle for capturing knowledge to ensure public health preparedness, managing information more effectively, enabling global health professionals to work collaboratively in a virtual environment, and improving effectiveness in the face of dwindling resources. Online CoPs provide a virtual space for people who share a common interest and are working towards a shared goal.  https://www.globalhealthlearning.org/course/online-communities-practice-cops-global-health  For those interested, examples of such CoPs you will find in: https://knowledge-gateway.org/ 

 

Those of the editorial board who participated in such online fora were of the opinion that we should not go this direction. The fear is that even with CoPs only a small percentage of those health professionals and stakeholders will be active participants in those discussions. However, make up your own mind and visit those mentioned websites. CoPs could be of interest for your situation!

 

Nevertheless, we would like to appeal to our readers to take up the challenge and contribute to ongoing discussions or bring new items. Once more, LML is an open forum – we welcome all contributions – accept the challenge and be open-minded! At the coming congress in Hyderabad a LML session will be held. Recently, we informed you about this and asked for questions to be discussed and answered during that session. This congress session will be transmitted by Zoom as well!

 

Last but no least, the members of the editorial board of LML past the retirement age ages ago. Is a younger generation willing to take up the challenge and safe-guard LML for the future? LML is needed, LML makes a difference.

 

 

Best wishes,


 

Editorial Board LML


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

 


--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/736f1fce-d418-4a1c-ac1d-cfd6a2e768abn%40googlegroups.com.

Friday, September 9, 2022

Fw: Ref.: (LML) Special Rapporteur on leprosy: Request for information for the HRC report


 
Leprosy Mailing List – September 9,  2022

 

Ref.:  (LML)  Special Rapporteur on leprosy: Request for information for the HRC report

 

From:  Alice Cruz, Quito, Ecuador

 

Dear Friends and Partners,


I have the honour to address you in my capacity as Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members, pursuant to Human Rights Council resolution 44/6


I would like to inform you that my forthcoming  report to the 53rd session of the Human Rights Council will consider issues related  to protection of persons affected by leprosy in the context of the right to development. Accordingly, I am seeking the views and inputs of Members and observer States, National Human Rights Institutions, United Nations agencies, international and regional organizations, and civil society, including non-governmental organizations and other relevant stakeholders. You are strongly encouraged to share the questionnaire with your national or regional branches and partners. The questionnaire is also available on the website of the Office of the High Commissioner for Human Rights.

(https://www.ohchr.org/EN/Issues/Leprosy/Pages/LeprosyIndex.aspx)


Please take part in this consultation and submit the completed questionnaire, which will substantively inform the forthcoming report, in any of English, French or Spanish hrc-sr-leprosy@un.org no later than 30 November 2022, using the email title: "Submissions to the Questionnaire 2022". Please clearly indicate your affiliation. Where possible please limit the response to the questionnaire to 1500 words. Supporting documents can be attached. Should you need any further information or clarification to this end, please do not hesitate to contact us by email.

 

Français

J'ai l'honneur de m'adresser à vous en ma qualité de Rapporteuse spéciale sur l'élimination de la discrimination à l'égard des personnes touchées par la lèpre et des membres de leur famille, conformément à la résolution 44/6 du Conseil des droits de l'homme. 

 

Je tiens à vous informer que mon prochain rapport à la 53e session du Conseil des droits de l'homme examinera les questions liées à la protection des personnes touchées par la lèpre dans le contexte du droit au développement. En conséquence, je sollicite les points de vue et les contributions des États membres et des États observateurs, des institutions nationales des droits de l'homme, des organismes des Nations Unies, des organisations internationales et régionales, et de la société civile, y compris les organisations non gouvernementales et autres parties prenantes concernées. Vous êtes vivement encouragés à partager le questionnaire avec vos branches et partenaires nationaux ou régionaux. Le questionnaire est également disponible sur le site Internet du Haut-Commissariat aux droits de l'homme. (https://www.ohchr.org/EN/Issues/Leprosy/Pages/LeprosyIndex.aspx)


Veuillez participer à cette consultation et soumettre le questionnaire complété, qui servira de base au rapport à venir, en anglais, français ou espagnol hrc-sr-leprosy@un.org au plus tard le 30 novembre 2022, en utilisant le titre de l'email : "Veuillez indiquer clairement votre affiliation. Dans la mesure du possible, veuillez limiter la réponse au questionnaire à 1500 mots. Des pièces justificatives peuvent être jointes. Si vous avez besoin de plus d'informations ou de précisions à ce sujet, n'hésitez pas à nous contacter par courrier électronique.

 

Espagnol

Tengo el honor de dirigirme a ustedes en mi calidad de Relator Especial sobre la eliminación de la discriminación contra las personas afectadas por la lepra y sus familiares, de conformidad con la resolución 44/6 del Consejo de Derechos Humanos. 


Quisiera informarle de que en mi próximo informe al 53º período de sesiones del Consejo de Derechos Humanos se examinarán cuestiones relacionadas con la protección de las personas afectadas por la lepra en el contexto del derecho al desarrollo. En consecuencia, estoy solicitando las opiniones y aportaciones de los Miembros y los Estados observadores, las Instituciones Nacionales de Derechos Humanos, los organismos de las Naciones Unidas, las organizaciones internacionales y regionales y la sociedad civil, incluidas las organizaciones no gubernamentales y otras partes interesadas pertinentes. Se les recomienda encarecidamente que compartan el cuestionario con sus filiales y socios nacionales o regionales. El cuestionario también está disponible en el sitio web de la Oficina del Alto Comisionado para los Derechos Humanos (https://www.ohchr.org/EN/Issues/Leprosy/Pages/LeprosyIndex.aspx)

 

Le rogamos que participe en esta consulta y envíe el cuestionario cumplimentado, que servirá de base para el próximo informe, en cualquiera de los idiomas inglés, francés o español hrc-sr-leprosy@un.org a más tardar el 30 de noviembre de 2022, utilizando el título del correo electrónico: "Submissions to the Questionnaire 2022". Por favor, indique claramente su afiliación. En la medida de lo posible, limite la respuesta al cuestionario a 1.500 palabras. Puede adjuntar documentos de apoyo. Si necesita más información o aclaraciones al respecto, no dude en ponerse en contacto con nosotros por correo electrónico.


Alice Cruz

Special Rapporteur on the Elimination of Discrimination against Persons Affected by Leprosy and their Family Members

 

Website: www.ohchr.org/EN/Issues/Leprosy/Pages/LeprosyIndex.aspx

Email: hrc-sr-leprosy@un.org

Facebook of the Special Rapporteur: https://www.facebook.com/srleprosy/

Tweeter of the Special Rapporteur: https://twitter.com/srleprosy

Instagram of the Special Rapporteur:

https://www.instagram.com/specialrapporteurleprosy/?hl=pt


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/08e36ed1-5fa2-4abd-8207-c4457841db77n%40googlegroups.com.

Fw: Ref.: (LML) LML Session at Leprosy Congress Hyderabad, India

 


Leprosy Mailing List – September 9,  2022

 

Ref.: (LML) LML Session at Leprosy Congress Hyderabad, India

From:  Ben Naafs, Munnekeburen, the Netherlands


Dear readers of LML,


Hopefully, you will be able to attend our LML congress meeting either physically or by Zoom. We like to present the program. As soon as possible we will inform you who will be the discussion leaders. 

Topic 1:  

How to improve the quality of clinical care during and after treatment? To prevent deterioration when in contact with the health services? How to improve the teaching? (This against the background of the past and present health care). 

Topic 2: 

Are ILEP members by their effort to raise money not increasing the stigma? How do you raise the money needed for care when the WHO and governments fail? ( Could we mirror AIDS by showing what happens when you are not treating and showing what you achieve by good care?).

Topic 3: 

Please send questions to LML and we will ask experts to answer these questions at the LML meeting.  

 

Kind regards,


Ben Naafs. Salvatore Noto, Pieter Schreuder and Sunil Deepak


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/14d5971a-f523-44f4-933a-a96918c89bd0n%40googlegroups.com.

Thursday, September 8, 2022

Fw: Ref.: (LML) Leprosy Review - September 2022

Leprosy Mailing List – September 8, 2022

 

Ref.:  (LML) Leprosy Review - September 2022

From:  Paul Saunderson, Ålesund, Norway

 

Dear Pieter,


I'm happy to report that the September issue of Leprosy Review is now freely available online at https://leprosyreview.org/articles

I've also attached the Table of Contents for your convenience.


With kind regards,


Paul


 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

Online journal freely available at: https://leprosyreview.org/

CONTENTS


179 Editor's Choice – September 2022
P. Saunderson
Editorial


180 PEP4LEP research and its contribution to capacity building
L. Mieras, on behalf of PEP4LEP Consortium


Original Papers


184 Epidemiological trends of leprosy and case detection delay in East Hararghe Zone, Ethiopia: A baseline survey, E. Mamo, K. Bobosha, M. Legesse, F. Daba, K. Debelo, T. Leta, T. Hambridge, A. Schoenmakers, R. van Wijk, C. Kasang, L. Mieras, and J. H. Richardus

197 Leprosy indicators and diagnosis delay in Mogovolas, Meconta and Murrupula district of Nampula Province, Mozambique: A baseline survey, A. Marega, T. Hambridge, Y. P. Stakteas, A. Schoenmakers, R. van Wijk, L. Mieras, P. H. das N. M. Pires, A. M. Muloliwa, F. Mitano, and J. H. Richardus


209 Leprosy epidemiological trends and diagnosis delay in three districts of Tanzania: A baseline study
N. Mwageni, D. Kamara, R. Kisonga, B. Njako, P. Nyakato, A. Pegwa, S. Marco, W. Mayunga, R. Hebron, S. Kidula, J. E. Masenga, T. Hambridge, A. Schoenmakers, R. van Wijk, L. Mieras, C. Kasang, J. H. Richardus, and S. E. Mshana


224 A hospital-based cross-sectional study of clinico-epidemiological aspects of childhood leprosy with disability in the post-elimination era N. Joy, S. Patnaik, S. Nayak, A. N. Rout, and I. Mohanty


235 Sensory nerve transfer to restore sole sensation in Hansen's disease, P. Agarwal, and D. Sharma


243 Health seeking behaviour of leprosy affected patients at a tertiary leprosy hospital during the COVID-19 pandemic, S. Paul, Sridharan D., Santhosam R., Vinothkumar M., and I. Horo


254 Social stigma and mental health impairment in people with leprosy: An integrative review
R. M. P. G. Costa, M. A. Fernandes, G. P. G. Santos, D. de M. Rocha, A. M. R. dos Santos, and F. V. S. D. Avelino


265 Stigma and art therapy with Brazilian leprosy patients, M. de L. G. Fernandes, A. R. N. de Souza, M. D. T. Kenedi, A. J. L. A. da Cunha, A. L. Kritski, and M. K. Gomes


Letter


288 Improving funding transparency to advance leprosy research A. Tucker, C. Cassard, and D. Scollard


Obituary


290 Miss June Elizabeth Nash. 19 May 1951–14 June 2022, J. Ebenso

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/076467e5-2c02-499c-b8a4-7f01fc56cd9an%40googlegroups.com.

Sunday, September 4, 2022

Fw: Ref.: (LML) New Publications On Cross-Cutting Issues In NTDs. August, 2022


 
Leprosy Mailing List – September 4,  2022

 

Ref.:  (LML) New Publications On Cross-Cutting Issues In NTDs. August, 2022

From:  Roos Geutjes, Amsterdam, the Netherlands

 



Dear colleagues, 

Have you already looked at the WHO Skin NTDs online course collection with new courses on onchocerciasis and noma? Please scroll down to find links to both courses. 

In order to eliminate neglected tropical diseases (NTDs), we must ensure access and uptake of NTD medicines for every individual at risk for these diseases. Please join USAID, Act to End NTDs East and RTI in their webinar 'Must Reach': Integrating Gender Equity and Social Inclusion to Eliminate NTDs. Scroll down to find more info. 

Enjoy reading the selection of the latest NTD publications that are listed below. We offer free full text delivery services. Feel free to contact us to receive the full-text versions if these cannot be found through the InfoNTD portal. We will also gladly support you with literature searches.


Warm regards,
Roos Geutjes

InfoNTD Coordinator
www.InfoNTD.org
info@InfoNTD.org
 

 



 



Practical materials

 



Future Brief on Communication in development cooperation - Part 1
Oomen W, Martens E. Partos and the Expertise Centre Humanitarian Communication. 2022.
 

A Guide to Improving MDA Using Qualitative Methods
Fitch E, Krentel A, Bardosh K, et al. RTI International. 2021.

 

Noma: training of health workers at national and district levels on skin-NTDs (online course)
World Health Organization. World Health Organization. 2022.
 

Onchocerciasis: training of health workers at national and district levels on skin-NTDs (online course)
World Health Organization. 2022. 


 

 



 



NTDs & COVID-19

 



Leishmaniasis control in the light of the COVID-19 pandemic in Africa
Uwishema O, Sapkota S, Wellington J, et al. Elsevier BV. Annals of Medicine and Surgery. 2022.

 

Challenges of addressing neglected tropical diseases amidst the COVID-19 pandemic in Africa: A case of Chagas Disease
Pradhan AU, Uwishema O, Wellington J, et al. Elsevier BV. Annals of Medicine and Surgery. 2022.
 

 



 



Other new publications

 



Community-based surveillance of infectious diseases: a systematic review of drivers of success
McGowan CR, Takahashi E, Romig L, et al. BMJ. BMJ Global Health. 2022; 7 (8) : e009934. 
 

The Connection between Climate Change, Surgical Care and Neglected Tropical Diseases
Shirley H, Grifferty G, Yates EF, et al. Ubiquity Press, Ltd.. Annals of Global Health. 2022.
 

In Defense of Mothers: Why Pregnant and Breastfeeding Women Should Be Included in Mass Drug Administration Programs
Lord MG. Mary Ann Liebert Inc. Journal of Women's Health. 2022.
 

Facilitators and barriers in implementation of mass drug administration for lymphatic filariasis elimination in India: A protocol for systematic review and qualitative meta-synthesis
Sahoo P, Sinha A, Mohapatra S, et al. Medknow. Journal of Family Medicine and Primary Care. 2022; 11 (7) : 3844. 
 

Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia
Gebrezgabiher G, Yewhalaw D, Hailu A, et al. Public Library of Science (PLoS). PLOS ONE. 2022; 17 (7) : e0271518. 
 

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin
Mnkai J, Marandu TF, Mhidze J, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (7) : e0010044. 
 

Optimal control problem and cost-effectiveness analysis of schistosomiasis model
Nur W, Trisilowati , Suryanto A, et al. AIP Publishing. THE 4TH INTERNATIONAL CONFERENCE ON NUCLEAR ENERGY TECHNOLOGIES AND SCIENCES (ICoNETS) 2021. 2022.
 

Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana
Adu Mensah D, Debrah LB, Gyamfi PA, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (8) : e0010129. 
 

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
Biamonte MA, Cantey PT, Coulibaly YI, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (8) : e0010682. 
 

Defining elimination as a public health problem for schistosomiasis control programmes: beyond prevalence of heavy-intensity infections
Wiegand RE, Fleming FM, de Vlas SJ, et al. Elsevier BV. The Lancet Global Health. 2022; 10 (9) : e1355-e1359. 
 

A novel theatre-based behaviour change approach for influencing community uptake of schistosomiasis control measures
Sule MN, Mosha J, Soboka TE, et al. Springer Science and Business Media LLC. Parasites &amp; Vectors. 2022.
 

Correlates of prior HIV testing and schistosomiasis treatment: baseline survey findings from the "creating demand for fishermen's schistosomiasis HIV services" (FISH) cluster-randomized trial in Mangochi, Malawi
Kangogo G, Conserve DF, Kayuni S, et al. Cold Spring Harbor Laboratory. 2022.
 

Stakeholders' Perspectives on the Application of New Diagnostic Devices for Urinary Schistosomiasis in Oyo State, Nigeria: A Q-Methodology Approach
Samenjo KT, Bengtson M, Onasanya A, et al. Johns Hopkins School Bloomberg School of Public Health, Center for Communication Programs. Global Health: Science and Practice. 2022.
 

WHO Alliance for the Global Elimination of Trachoma: progress report on elimination of trachoma, 2021
World Health Organization . World Health Organization. Weekly epidemiological record. 2022.
 

Comorbidities involving parasitic diseases: A look at the benefits and complications
Oliveira FMS, Cruz RE, Pinheiro GRG, et al. SAGE Publications. Experimental Biology and Medicine. 2022.
 

Simple and structured model to build sequencing capacity in west Africa
Kanteh A, Manneh J, Sanyang B, et al. Elsevier BV. The Lancet Global Health. 2022; 10 (9) : e1240-e1241. 
 

Barriers and facilitators to Water, Sanitation and Hygiene (WaSH) practices in Southern Africa: A scoping review
Tseole NP, Mindu T, Kalinda C, et al. Public Library of Science (PLoS). PLOS ONE. 2022; 17 (8) : e0271726. 
 

The role of communication, building relationships, and adaptability in non-profit organisational capacity for health promotion
van Herwerden LA, Reidlinger DP, Palermo C. Oxford University Press (OUP). Health Promotion International. 2022.
 

Global commitment to action on NTDs and malaria
Jesudason T. Elsevier BV. The Lancet Infectious Diseases. 2022; 22 (9) : 1285.
 

Global commitment to action on NTDs and malaria
Jesudason T. Elsevier BV. The Lancet Infectious Diseases. 2022; 22 (9) : 1285.
 

Exploring benefits and ethical challenges in the rise of mHealth (mobile healthcare) technology for the common good: An analysis of mobile applications for health specialists
Galetsi P, Katsaliaki K, Kumar S. Elsevier BV. Technovation. 2022.
 

Nineteenth meeting of the Regional Programme Review Group and national neglected tropical diseases programme managers
World Health Organization. World Health Organization Regional Office for the Eastern Mediterranean (WHO/EMRO). 2022; 28 (2) : 169-170. 

 


Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society
Menaldi SL, Harini M, Nelfidayani N, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (8) : e0010646.
 

A qualitative process evaluation of a community conversation intervention to reduce stigma related to lower limb lymphoedema in Northern Ethiopia
Tora A, Kinfe M, Ali O, et al. Springer Science and Business Media LLC. BMC Health Services Research. 2022.
 

The Amazonian Tropical Bites Research Initiative, a hope for resolving zoonotic neglected tropical diseases in the One Health era
Taylor E, Aguilar-Ancori EG, Banyard AC, et al. Oxford University Press (OUP). International Health. 2022.
 

Barriers and Enablers to Health-Seeking for People Affected by Severe Stigmatising Skin Diseases (SSSDs): A Scoping Review
McCollum R, Berrian H, Theobald S, et al. MDPI AG. Social Sciences. 2022; 11 (8) : 332. .
 

Financing Care for Severe Stigmatizing Skin Diseases (SSSDs) in Liberia: Challenges and Opportunities
Smith JS, Diaconu K, Witter PS, et al. Research Square Platform LLC. 2022.
 

Quantifying Population Burden and Effectiveness of Decentralized Surveillance Strategies for Skin-Presenting Neglected Tropical Diseases, Liberia
Timothy JW, Rogers E, Halliday KE, et al. Centers for Disease Control and Prevention (CDC). Emerging Infectious Diseases. 2022; 28 (9) : 1755-1764. 
 

An analysis of social dimensions of podoconiosis and leprosy on affected households in endemic health districts of the North West Region of Cameroon
Tembei AM, Kengne-Ouafo JA, John B, et al. Elsevier BV. SSM - Population Health. 2022.
 

Early Detection and Case Management of Skin Diseases with a Mobile Health Application 'eSkinHealth': Protocol for a Mixed-Methods Pilot Study in Côte d'Ivoire.
Yotsu R, Itoh S, Yao K, et al. JMIR research protocols. 2022.
 

Mechanisms of action for stigma reduction among primary care providers following social contact with service users and aspirational figures in Nepal: an explanatory qualitative design
Kaiser BN, Gurung D, Rai S, et al. Springer Science and Business Media LLC. International Journal of Mental Health Systems. 2022.
 

Self-Care Practice and Its Associated Factors Among Podoconiosis Patients in East Gojjam Zone, North West Ethiopia
Esubalew H, Wubie M, Tafere Y, et al. Informa UK Limited. Patient Preference and Adherence. 2022.
 

Mycetoma management and clinical outcomes: the Mycetoma Research Center experience
Musa EA, Abdoon IH, Bakhiet SM, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2022.
 

Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach
Seas C, Legua P. Ovid Technologies (Wolters Kluwer Health). Current Opinion in Infectious Diseases. 2022.
 

Scabies among children in Ethiopia
Marmara D, Mulugeta H, Thygerson S, et al. Institute of Advanced Engineering and Science. International Journal of Public Health Science (IJPHS). 2022; 11 (3) : 989.
 

Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs
da Conceição JR, Lopes CGP, Ferreira EI, et al. Elsevier BV. Acta Tropica. 2022.
 

Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination
Shrestha H, McCulloch K, Hedtke SM, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (7) : e0010620.

 

Possible clinical implications and future directions of managing bacterial biofilms in cutaneous leishmaniasis wounds
Kaluarachchi TDJ, Campbell PM, Wickremasinghe R, et al. Springer Science and Business Media LLC. Tropical Medicine and Health. 2022.
 

Social determinants of health and the double burden of disease in Nepal: a secondary analysis
Gardner H, Miles G, Saleem A, et al. Springer Science and Business Media LLC. BMC Public Health. 2022.
 

Direct economic impact of Chagas disease treatment
Zaidel EJ, Sosa Liprandi Á. SAGE Publications. Therapeutic Advances in Infectious Disease. 2022.
 

The long-term impact of an Ecohealth intervention: Entomological data suggest the interruption of Chagas disease transmission in southeastern Guatemala
Pereira FM, Penados D, Dorn PL, et al. Elsevier BV. Acta Tropica. 2022.
 

An artificial intelligence model to identify snakes from across the world: Opportunities and challenges for global health and herpetology
Bolon I, Picek L, Durso AM, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (8) : e0010647. 
 

Housing Risk Factors of Four Tropical Neglected Diseases: A Brief Review of the Recent Literature
Chastonay AHM, Chastonay OJ. MDPI AG. Tropical Medicine and Infectious Disease. 2022; 7 (7) : 143. 
 

DNA biosensor based detection for neglected tropical disease: moving towards smart diagnosis
Stephen BJ, Suchanti S, Jain D, et al. Emerald. Sensor Review. 2022.
 

 



 



Governance & Health Systems

 



Tracking Universal Health Coverage in the WHO African Region, 2022
World Health Organization. World Health Organization. 2022.
 

Assessing the scalability of a health management-strengthening intervention at the district level: a qualitative study in Ghana, Malawi and Uganda
Bulthuis S, Kok M, Onvlee O, et al. Springer Science and Business Media LLC. Health Research Policy and Systems. 2022.
 

How medical education holds back health equity
Naidu T, Abimbola S. Elsevier BV. The Lancet. 2022.
 

A new research agenda for Africa's international relations
Tieku TK. Oxford University Press (OUP). African Affairs. 2022; 121 (484) : 487-499. 
 

Partnering to Advance Health Equity and a Welcome Opportunity to Gather: Proceedings From the 28th Annual Conference of the Health Care Systems Research Network
Greenlee RT. Aurora Health Care, Inc.. Journal of Patient-Centered Research and Reviews. 2022; 9 (3) : 193-195. 
 

Achieving basic rights in health-care facilities in low-income countries
Hannah E, O'Hare B, Lopez M, et al. Elsevier BV. The Lancet Global Health. 2022; 10 (9) : e1243. 
 

Progress on the health-related Sustainable Development Goals and targets in the Eastern Mediterranean region, 2020
World Health Organization. World Health Organization. 2022.
 

From Health in All Policies to Health for All Policies
Greer SL, Falkenbach M, Siciliani L, et al. Elsevier BV. The Lancet Public Health. 2022; 7 (8) : e718-e720. 

 



 



News & Webinars

 



Webinar: 'Must Reach': Integrating Gender Equity and Social Inclusion to Eliminate NTDs 
Please join them to learn how Haiti, Tanzania, and Uganda implemented game-changing community-led behavior change activities and improved access, acceptance, and uptake of mass drug administration among 'must reach' groups.
Sep 8, 2022 08:00 AM in Eastern Time (US and Canada)
Don't forget to register! 
 

Masterclass Power Structures in Development and Human Rights – from an African feminist perspective
How can we create global solidarity that makes better use of each other's strengths? How can we be equal partners? Looking at things and struggles from an African feminist perspective and intersectionality can help. The series kicks off on the 7th of September at 8.30 EAT, but will consist of 6 different online masterclasses about power structures and privileges in the field of development and human rights. 

 


The 7th Global Symposium on Health Systems Research (HSR2022)
HSR2022 will explore the following sub-themes:

  • The politics and policies of health systems
  • Intersectoral collaboration and integrative governance on the road for health in all policies
  • The changing dynamics of health provision models to promote equity and the central role of human resources for health
  • The role of comprehensive primary care in promoting sustainability and the contribution of new technologies

Symposium date: Oct 31th - Nov 4th, Bogota 
 

NTD NGO Network (NNN) Conference - Registration is open!
The NNN is delighted to announce that this year's NTD NGO Network (NNN) Annual Conference will take place from Tuesday 13th to Thursday 15th September 2022
The event will be in a Hybrid format, taking place in-person in Kathmandu, Nepal as well as some elements being streamed virtually. 
Have you registered for the conference? 

 




GDPR & the InfoNTD newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

InfoNTD sends out monthly e-mails with an overview of recent publications on NTDs and cross-cutting issues. The purpose of this activity is to keep subscribers up to date.

InfoNTD will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 


 


 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/22d1b94a-311d-4328-b339-dce42baa0cden%40googlegroups.com.